Suzanne Epstein
Suzanne Epstein
Associate Director for Research, FDA, CBER, OTATT
Потвърден имейл адрес: fda.hhs.gov
Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture
G Franzoso, L Carlson, L Poljak, EW Shores, S Epstein, A Leonardi, ...
The Journal of experimental medicine 187 (2), 147-159, 1998
Protection against lethal influenza virus challenge by RNA interference in vivo
SM Tompkins, CY Lo, TM Tumpey, SL Epstein
Proceedings of the National Academy of Sciences 101 (23), 8682-8686, 2004
Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1
SM Tompkins, ZS Zhao, CY Lo, JA Misplon, T Liu, Z Ye, RJ Hogan, Z Wu, ...
Emerging infectious diseases 13 (3), 426, 2007
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
SL Epstein, W Kong, JA Misplon, CY Lo, TM Tumpey, L Xu, GJ Nabel
Vaccine 23 (46-47), 5404-5410, 2005
Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature
SL Epstein
The Journal of infectious diseases 193 (1), 49-53, 2006
TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection
I Jelinek, JN Leonard, GE Price, KN Brown, A Meyer-Manlapat, ...
The Journal of Immunology 186 (4), 2422-2429, 2011
Mechanism of protective immunity against influenza virus infection in mice without antibodies
SL Epstein, CY Lo, JA Misplon, JR Bennink
The Journal of Immunology 160 (1), 322-327, 1998
DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice
SL Epstein, TM Tumpey, JA Misplon, CY Lo, LA Cooper, K Subbarao, ...
Emerging infectious diseases 8 (8), 796, 2002
Critical roles for the Bcl-3 oncoprotein in T cell–mediated immunity, splenic microarchitecture, and germinal center reactions
G Franzoso, L Carlson, T Scharton-Kersten, EW Shores, S Epstein, ...
Immunity 6 (4), 479-490, 1997
Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of …
NA Giese, L Gabriele, TM Doherty, DM Klinman, L Tadesse-Heath, ...
The Journal of experimental medicine 186 (9), 1535-1546, 1997
Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells
KA Benton, JA Misplon, CY Lo, RR Brutkiewicz, SA Prasad, SL Epstein
The Journal of Immunology 166 (12), 7437-7445, 2001
Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.
SL Epstein, CY Lo, JA Misplon, CM Lawson, BA Hendrickson, EE Max, ...
Journal of immunology (Baltimore, Md.: 1950) 158 (3), 1222-1230, 1997
Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
GE Price, MR Soboleski, CY Lo, JA Misplon, C Pappas, KV Houser, ...
Vaccine 27 (47), 6512-6521, 2009
Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses
GE Price, MR Soboleski, CY Lo, JA Misplon, MR Quirion, KV Houser, ...
PloS one 5 (10), e13162, 2010
Cross-protective immunity to influenza A viruses
SL Epstein, GE Price
Expert review of vaccines 9 (11), 1325-1341, 2010
Antigen-antibody interaction and monoclonal antibodies
IA Berzofsky
Fundamental immunology, 421-425, 1993
Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
SL Epstein, JA Misplon, CM Lawson, EK Subbarao, M Connors, ...
Journal of immunology (Baltimore, Md.: 1950) 150 (12), 5484-5493, 1993
Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies
CY Lo, Z Wu, JA Misplon, GE Price, C Pappas, WP Kong, TM Tumpey, ...
Vaccine 26 (17), 2062-2072, 2008
Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza
N Arinaminpathy, O Ratmann, K Koelle, SL Epstein, GE Price, C Viboud, ...
Proceedings of the National Academy of Sciences 109 (8), 3173-3177, 2012
Induction of anti-H–2 antibodies without alloantigen exposure by in vivo administration of anti-idiotype
JA Bluestone, SO Sharrow, SL Epstein, K Ozato, DH Sachs
Nature 291 (5812), 233-235, 1981
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20